Onconetix Inc (NASDAQ:ONCO) does about 12.93M shares in volume on a normal day but saw 956700 shares change hands in the recent trading day. The company now has a market cap of 4.42M USD. Its current market price is $0.15, marking a decrease of -4.12% compared to the previous close of $0.16. The 52 week high reached by this stock is $0.90 whilst the lowest price level in 52 weeks is $0.10.
Onconetix Inc (ONCO) has a 20-day trading average at $0.1463 and the current price is -83.44% off the 52-week high compared with 48.85% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.1548 and its 200-day simple moving average is $0.1792. If we look at the stock’s price movements over the week, volatility stands at 12.98%, which increases to 13.07% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 48.72 to suggest the stock is neutral.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 98.33% over the period.
#####
#####
The current price level is 1.25%, -3.68%, and -17.33% away from its SMA20, SMA50, and SMA200 respectively, with the ONCO price moving above the 50-day SMA on current market day. Onconetix Inc (ONCO) stock is down -0.60% over the week and -15.82% over the past month. Its price is -24.75% year-to-date and -82.87% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/30/2023, with the company’s earnings per share (EPS) of -0.2 above consensus estimates by 0.06. The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year. In addition, estimates put the company’s current quarterly revenue at an average of $58k.
To reach the target analysts have set, the stock logically needs to grow 98.33 percent from here.
Outstanding shares total 29.68M with insiders holding 6.44% of the shares and institutional holders owning 14.15% of the company’s common stock. The company has a return on investment of -106.58% and return on equity of -146.42%. The beta has a value of 3.68. Price to sales ratio is 5.82.
#####
